| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/14/2007 | US7256026 Activated yeast cell culture for improving immune functions of animals; health foods, drinks and supplement; immunosuppression; immunotherapy |
| 08/14/2007 | US7255921 Non-gelatinous capsule shell composition and a capsule formed from the same |
| 08/14/2007 | US7255886 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of Diabetes mellitus |
| 08/14/2007 | US7255881 For therapy of undesirable skin conditions |
| 08/14/2007 | US7255878 Stable benzimidazole formulation |
| 08/14/2007 | US7255877 Fenofibrate microparticles |
| 08/14/2007 | US7255876 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/14/2007 | US7255875 Integrin targeted imaging agents |
| 08/14/2007 | US7255874 Use as sealants and adhesives for medical uses, and as polymeric formulations for biocompatible implants and matrices and drug delivery |
| 08/14/2007 | US7255869 Mixture of hydrophilic and hydrophobic alcohols; topical applying to hair |
| 08/14/2007 | US7255867 Group A streptococcal antigen combined with proteosome adjuvant; prevention or reduction of throat colonization; intranasal administration |
| 08/14/2007 | US7255690 Infusion device having piston operated driving mechanism and positive pressure reservoir |
| 08/14/2007 | US7255102 Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin |
| 08/14/2007 | CA2307547C Chronotherapeutic diltiazem formulations and the administration thereof |
| 08/14/2007 | CA2241931C Use of molecular sieves to promote wound healing |
| 08/14/2007 | CA2223259C Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 08/14/2007 | CA2215748C Freeze-drying process and apparatus |
| 08/14/2007 | CA2173504C Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 08/14/2007 | CA2128372C Maltose-trehalose converting enzyme, and preparation and uses thereof |
| 08/10/2007 | CA2572764A1 Local system for the release of active principle and process for its manufacture |
| 08/09/2007 | WO2007090113A2 Use of antifungal compositions to treat upper gastrointestinal conditions |
| 08/09/2007 | WO2007089981A1 System and apparatus for controlled activation of acute use medical devices |
| 08/09/2007 | WO2007089931A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/09/2007 | WO2007089912A2 Methods of making medical devices |
| 08/09/2007 | WO2007089878A2 Sutures and anti-scarring agents |
| 08/09/2007 | WO2007089864A2 Sutures and fibrosing agents |
| 08/09/2007 | WO2007089544A2 Biodegradable non-ophthalmic implants and related methods |
| 08/09/2007 | WO2007089247A1 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 08/09/2007 | WO2007089166A1 Medicinal preparation for jugulating a systemic inflammatory response syndrome |
| 08/09/2007 | WO2007089043A1 Liposome preparation |
| 08/09/2007 | WO2007088952A1 Liposome preparation comprising substance having anti-tumor activity |
| 08/09/2007 | WO2007088783A1 Eye drop/wearing fluid for soft contact lenses |
| 08/09/2007 | WO2007088343A2 Granular material comprising water- insoluble inorganic phosphate binders |
| 08/09/2007 | WO2007088327A1 Composition for promoting vascular smooth muscle relaxation |
| 08/09/2007 | WO2007088035A1 A pharmaceutical composition comprising perindopril |
| 08/09/2007 | WO2007087872A1 Transdermal therapeutic system for volatile and/or thermolabile substances |
| 08/09/2007 | WO2007087806A1 A topical composition comprising an antibacterial substance |
| 08/09/2007 | WO2007087805A1 Carboxylic acid esters of mono- and di-glycerides as a dispersing agent |
| 08/09/2007 | WO2007087759A2 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 08/09/2007 | WO2007060512A3 Compositions containing topical active agents and pentylene glycol |
| 08/09/2007 | WO2007054976A3 Lipid based controlled release pharmaceutical composition |
| 08/09/2007 | WO2007054968A3 Novel pharmaceutical compositions of clopidogrel mesylate |
| 08/09/2007 | WO2007052164A3 A pharmaceutical formulation containing olanzapine |
| 08/09/2007 | WO2007047744A3 Method for treating primary and secondary forms of glaucoma |
| 08/09/2007 | WO2007039760A3 Use of oligouronates for treating mucus hyperviscosity |
| 08/09/2007 | WO2007039533A3 Antifungal composition |
| 08/09/2007 | WO2007030153A3 Compositions containing micronized tanaproget |
| 08/09/2007 | WO2007024719A3 Long acting injectable parasiticidal formulations |
| 08/09/2007 | WO2007024700A3 Exendin for treating diabetes and reducing body weight |
| 08/09/2007 | WO2007022924A3 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 08/09/2007 | WO2007021805A3 Estrogen compositions and therapeutic methods of use thereof |
| 08/09/2007 | WO2007021754A3 Diltiazem controlled release formulation and method of manufacture |
| 08/09/2007 | WO2007018885A3 A method for processing drugs |
| 08/09/2007 | WO2007010509A3 Controlled release pharmaceutical composition comprising alpha-adrenergic antagonist and muscarinic antagonist |
| 08/09/2007 | WO2007002823A3 Formulations of conjugated estrogens and bazedoxifene |
| 08/09/2007 | WO2006127044A3 Pharmaceutical formulations useful for inhibiting acid secretion |
| 08/09/2007 | WO2006123329B1 Disposable dispenser for patient infusion |
| 08/09/2007 | WO2006122217A3 Supersaturated benzodiazepine solutions and their delivery |
| 08/09/2007 | WO2006083946A3 Method and device for selective addition of a bioactive agent to a multi-phase implant |
| 08/09/2007 | WO2006081293A8 Delivery of bio-available compounds with anhydrous topical preparations |
| 08/09/2007 | WO2006076065A3 Personal care compositions |
| 08/09/2007 | WO2004082612A3 Liposomal formulations and methods of use |
| 08/09/2007 | US20070185218 Controlled release formulation for oral administration of metformin |
| 08/09/2007 | US20070185194 Stable oral compositions of azithromycin monohydrate |
| 08/09/2007 | US20070185082 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 08/09/2007 | US20070185076 Antibiotic for gramnegative bacteria; prepared as an aerosolable saline solution |
| 08/09/2007 | US20070185067 Ciclesonide and glycopyrronium combination |
| 08/09/2007 | US20070185033 Pharmaceutical formulations for sustained drug delivery |
| 08/09/2007 | US20070185032 Wter insolble complex of polypeptide and macromolecular carrier |
| 08/09/2007 | US20070185008 Stereocomplex hydrogels with tunable degradation times |
| 08/09/2007 | US20070184267 Phototpolymerized macromolecules self-assembled around carbon nanotubes, a method of producing them, and their applications |
| 08/09/2007 | US20070184121 Healthcare and cosmetic compositions containing nanodiamond |
| 08/09/2007 | US20070184120 Adhesin-specific nanoparticles and process for using same |
| 08/09/2007 | US20070184119 Surface modified protein microparticles |
| 08/09/2007 | US20070184118 Compositions and methods for oxalate reduction |
| 08/09/2007 | US20070184117 Tocopheryl polyethylene glycol succinate powder and process for preparing same |
| 08/09/2007 | US20070184116 Pharmaceutical formulation containing unmilled flutamide |
| 08/09/2007 | US20070184115 Modified release formulations of tramadol and uses thereof |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184113 Pharmaceutical composition and process |
| 08/09/2007 | US20070184112 Volume Efficient Controlled Release Dosage Form |
| 08/09/2007 | US20070184111 Hybrid tablet |
| 08/09/2007 | US20070184110 Dipyridamole extended-release formulations and process for preparing same |
| 08/09/2007 | US20070184108 Stable pharmaceutical formulations of montelukast sodium |
| 08/09/2007 | US20070184107 Moisture resistant container systems for rapidly bioavailable dosage forms |
| 08/09/2007 | US20070184106 Blister packaging for acute pain regimens |
| 08/09/2007 | US20070184105 Comsposition for stablizing epigallocatechin gallate (egcg) in water phase and preparation method thereof |
| 08/09/2007 | US20070184104 Gastric retentive gabapentin dosage forms and methods for using same |
| 08/09/2007 | US20070184103 Process for producing fenofibrate tablets |
| 08/09/2007 | US20070184102 Latex or pseudolatex compositions, coatings and coating processes |
| 08/09/2007 | US20070184101 Stable pharmaceutical formulations of montelukast sodium |
| 08/09/2007 | US20070184100 Contains a solid ibuprofen free acid and a solid ibuprofen alkali salt, and is characterized in that at least 90% of the weight of the solid ibuprofen concentrate is ibuprofen free acid and ibuprofen alkali salt; immediate release analgesics |
| 08/09/2007 | US20070184099 Films for use as dosage forms |
| 08/09/2007 | US20070184098 Esters of flavonoids with w-substituted c6-c22 fatty acids |
| 08/09/2007 | US20070184097 Adhesive preparations |
| 08/09/2007 | US20070184096 Stable Therapeutic Formulations |
| 08/09/2007 | US20070184094 Method for producing a metallic temporary tattoo |
| 08/09/2007 | US20070184093 Dissolving films |
| 08/09/2007 | US20070184089 Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use |
| 08/09/2007 | US20070184082 Biocompatible polymeric delivery systems for sustained release of quinazolinones |